WuXi Biologics ISIN: KYG970081173 Forum: Aktien User: Summer.76

https://www.prnewswire.com/news-releases/wuxi-biologics-congratulates-amicus-therapeutics-on-european-commission-approval-for-pombiliti-in-patients-with-late-onset-pompe-disease-301783244.html

Also das klingt ja alles vielversprechend. Der Kurs spiegelt die positiven Ergebnisse ja noch nicht besonders wider.

https://www.prnewswire.com/news-releases/wuxi-biologics-reports-remarkable-2022-annual-results-301778513.html WuXi Biologics Reports Remarkable 2022 Annual Results

🎈

https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/with-wuxi-biologics-cayman-incs-hkg2269-price-down-59-this-w/amp

https://seekingalpha.com/article/4580154-after-2022-slowdown-wuxi-biologics-gets-growth-medicine-big-new-order After 2022 Slowdown, WuXi Biologics Gets Growth Medicine From Big New Order Summary • WuXi Biologics revenue growth slowed sharply to 48.4% last year, but it got a jumpstart with its signing of a major new order last month. • The company's major shareholder recently sold 56 million shares, the latest in a steady series of such sales since its listing in 2017. • Investors are likely drawn to the company’s steady growth, though it will need to show it can return to the high-growth fast lane after last year’s modest slowdown. ...

https://m.hk.investing.com/news/stock-market-news/article-296039

Big Bank Rating | Nomura: Maintain WuXi Biologics (2269 HK) Buy rating and target price cut to HK$94.91 https://finance.sina.cn/hkstock/sckxjfx/2023-02-14/detail-imyfrvfw9195388.d.html?from=wap

Zhongtai Securities: „Kauf“-Rating von WuXi Biologics (02269) beibehalten, Kommerzialisierungsprojekte dürften weiterhin an Volumen zunehmen https://m.hk.investing.com/news/stock-market-news/article-295664

Wuxi Biologics Slips on Lower-Than-Expected Guidance https://www.marketwatch.com/amp/story/wuxi-biologics-slips-on-lower-than-expected-guidance-3c76f7aa

POSITIVE PROFIT ALERT Download https://doc.irasia.com/listco/hk/wuxibiologics/announcement/a230213.pdf

DATE OF BOARD MEETING Download https://doc.irasia.com/listco/hk/wuxibiologics/announcement/a230213a.pdf

"Profit Forecast" WuXi Biologics (02269 HK) Estimates Annual Earnings 30% More, Revenue Increases 48% http://www.aastocks.com/tc/stocks/news/aafn-news/NOW.1244741/1

http://www.aastocks.com/en/stocks/news/aafn-con/now.1244673/latest-news

https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/does-wuxi-biologics-cayman-hkg2269-deserve-a-spot-on-your-wa/amp